Legal cannabis has generated nearly $25 billion in tax revenue, with $4.4 billion collected in 2024 alone. States benefit significantly, funding various community programs. However, equity issues remain, as many who contributed to legalization are still marginalized. The promise of justice is overshadowed by bureaucracy and economic barriers for legacy growers.
DEA Stalls on Cannabis Rescheduling: What’s the Hold-Up?
The DEA is dragging its feet on cannabis rescheduling despite over 43,000 public comments and a formal Schedule III recommendation from HHS. What’s the hold-up? This deep-dive exposes the legal limbo, political stall tactics, and why America’s weed policy is still frozen in time.
The DEA’s Stance on Rescheduling: Progress or Stalemate?
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.
Ex-Philippines President Duterte Arrested, Flown to The Hague for ICC Trial
Rodrigo Duterte, former president of the Philippines, was arrested and extradited to The Hague to face charges of crimes against humanity for his brutal war on drugs, which resulted in thousands of deaths. His trial marks a significant moment for global accountability, as many countries evaluate their own drug policies in light of his actions.
The Psychedelic Revolution: How Cannabis Opened the Door for Legal Shrooms and Beyond
Explore how cannabis legalization is paving the way for the Psychedelic Renaissance and what this means for mental health treatment and societal norms
Psychedelic Renaissance: How Cannabis is Opening the Door for Legal Psychedelics
Explore how cannabis legalization is paving the way for the acceptance of psychedelics like psilocybin and MDMA. Discover the cultural, political, and scientific shifts driving this new wave of drug reform